
Anthony D’Amico, MD, PhD; Daniel P. Petrylak, MD; and Nicholas J. Vogelzang, MD, review the most significant prostate cancer data and its clinical implications on improving patient outcomes.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe diagnostic, prognostic, and prevention tools and strategies for prostate cancer patients
- Discuss recent data from clinical studies of approved and investigational treatments for prostate cancer
- Identify new insights into optimal clinical management strategies for patients with prostate cancer